Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral…

Overview of attention for article published in Journal of Hematology & Oncology, January 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

So far, Altmetric has seen 19 X posts from 18 X users, with an upper bound of 68,289 followers.

Total of 7 patients with HIV (PWH) and lymphoma treated with anti-CD19 CAR from real world data from 3 different studies... https://t.co/Jnc2Sgxv1o https://t.co/KPmyUFLQfX https://t.co/x4kMxFPWDA

RT @Amitvermamds: Real world use of CD19 CART Yescarta in Lymphoma shows efficacy in patients with HIV, HCV and CNS disease. Well tolerated…

RT @Amitvermamds: Real world use of CD19 CART Yescarta in Lymphoma shows efficacy in patients with HIV, HCV and CNS disease. Well tolerated…

RT @sisodoc: Our experience with first 10 R/R Large B-cell lymphoma treated with CAR-T. https://t.co/xbYzXAfVwm @Amitvermamds @MontefioreNY…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 15 additional X posts.